Page 1 of 1

#1

Posted: Mon Apr 06, 2026 6:00 pm
by RSS Post Bot
Ixekizumab plus tirzepatide (IXE+TZP) shows significant benefits for outcomes in psoriatic arthritis (PsA) versus IXE alone in adults with overweight or obesity, according to a study presented at the annual meeting of the American Academy of Dermatology, held from March 27 to 31 in Denver.

Source: https://medicalxpress.com/news/2026-04- ... ritis.html